Clinical Trial Update: FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study [Phase 2]

View source ↗

Summary

A Phase 2 study (FUCHSia) evaluating fulvestrant for hormone-sensitive gynecologic cancers has completed, investigating its activity in uterine and ovarian tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenosarcoma of the Uterus
• Endometrial Cancer
• Endometrial Stromal Sarcoma
• Ovarian Serous Tumor
• Sex Cord-stromal Tumor
• Uterine Leiomyosarcoma

Drugs mentioned

• Fulvestrant (fulvestrant)

Snippet

Sponsor: Frederic Amant | Conditions: Endometrial Stromal Sarcoma, Adenosarcoma of Uterus | Phase 2 | Status: COMPLETED